A detailed history of Whitebox Advisors LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Whitebox Advisors LLC holds 250,100 shares of ITCI stock, worth $33 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
250,100
Holding current value
$33 Million
% of portfolio
1.79%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$81.78 - $131.92 $22.5 Million - $36.3 Million
275,001 New
275,001 $36.3 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.4B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Whitebox Advisors LLC Portfolio

Follow Whitebox Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitebox Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whitebox Advisors LLC with notifications on news.